Abstract
Initial exploratory tests, and trials of the use of exogenous interferon in man have had fairly promising results (1–7); however, further more extensive trials will probably be restricted by limitations in the supply of interferon. Almost all trials of interferon in man have, up to now, been performed using leukocyte-derived interferon produced by induction with Sendai virus (8). This system of production is dependent on the supply of human blood buffy coats, and this factor alone restricts expansion of production from present levels.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahstrom, L., A. Dohlwitz, H. Strander, and K. Cantell. 1974. Interferon in acute leukaemia in children. Lancet i: 166–167.
Cantell, K., L. Pyhala, and H. Strander. 1974. Circulating human interferon after intramuscular injection into animals and man. J. Gen. Virol. 22: 453–455.
Desmyter, J., J. DeGroote, V. J. Desmet, A. Billiau, M. B. Ray, A. F. Bradburne, V. G. Edy, P. DeSomer, and J. Mortelmans. 1976. Administration of human fibroblast interferon in chronic hepatitis B infection. Lancet ii: 645–647.
Greenberg, H. D., R. B. Pollard, L.I. Lutwick, P. B. Gregory, W. S. Robinson, and T. C. Merigan. 1976. Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. New Engl. J. Med. 295: 517–522.
Jordan, G. W., R. P. Fried, and T.C. Merigan. 1974. Administration of human leukocyte interferon in herpes zoster: safety, circulating antiviral activity, and host responses to infection. J. Infect. Dis. 130: 56–62.
Merigan, T. C., S. E. Reed, T. S. Hall, and D. A. J. Tyrrell. 1973. Inhibition of respiratory virus infection by locally applied interferon. Lancet i: 563–567.
Strander, H., K. Cantell, G. Carlstrom, and P.A. Jakobsson. 1973. Clinical and laboratory investigations on man: systemic administration of potent interferon to man. J. Natl. Cancer Inst. 51: 733–742.
Cantell, K., S. Hirvonen, K. E. Mogensen, and L. Pyhala. 1974. Human leukocyte interferon: purification, stability and animal experiments. Pgs. 35–38 in C. Waymouth, ed. The Production and Use of Interferon for the Treatment and Prevention of Human Virus Infections. The Tissue Culture Association, Rockville.
Strander, H., K. E. Mogensen, and K. Cantell. 1975. Production of human lymphoblastoid interferon. J. Clin. Microbiol. 1: 116–117.
Haveil, E. A., and J. Vilcek. 1972. Production of high-titered interferon in cultures of human diploid cells. Antimicrob. Ag. Chemother. 2: 476–484.
Billiau, A., M. Jordan, and P. DeSomer. 1973. Mass production of human interferon in diploid cells stimulated by poly-I:C. J. Gen. Virol. 19: 1–8.
Ho, M., J. M. Tan, and J. A. Armstrong. 1972. Accentuation of production of human interferon by metabolic inhibitors. Proc. Soc. Exp. Biol. Med. 139: 259–262.
Bonin, O., I. Schmidt, K. Schmidt, R. Mauler, and H. Gruschkau. 1974. Calf serum content of cell culture grown viral vaccines and possibilities for its reduction. J. Biol. Standard. 2: 139–141.
Stewart II, W. E., L. B. Gosser, and R. Z. Lockart. 1971. Priming: a non-antiviral function of interferon. J. Virol. 7: 792–801.
House, W., M. Shearer, and N. G. Maroudas. 1972. Method for bulk culture of animal cells or plastic film. Exp. Cell. Res. 71: 293–296.
Edy, V. G., I. A. Braude, E. DeClercq, A. Billiau, and P. DeSomer. 1976. Purification of interferon by adsorption chromatography on controlled pore glass. J. Gen. Virol. 33: 517–521.
Edy, V. G., M. Joniau, A. Billiau, and P. DeSomer. 1974. Stabilisation of mouse and human interferons by acid pH against inactivation due to shaking and guanidine hydrochloride. Proc. Soc. Exp. Biol. Med. 146: 249–253.
Havell, E. A., B. Berman, C. A. Ogburn, K. Berg, K. Paucker, and J. Vilcek. 1975. Two antigenically distinct species of human interferon. Proc. Nat. Acad. Sci. 72: 2185–2187.
Stewart II, W. E., P. DeSomer, V. G. Edy, K. Paucker, K. Berg, and C. A. Ogburn. 1975. Distinct molecular species of human interferons: requirements for stabilization and reactivation of human leukocyte and fibroblast interferons. J. Gen. Virol. 26: 327–331.
Edy, V.G., A. Billiau, and P.DeSomer. 1976. Human fibroblast and leukocyte interferons show different dose- response curves in assay of cell protection. J. Gen. Virol. 31: 251–255.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Plenum Press, New York
About this chapter
Cite this chapter
Edy, V.G., VanDamme, J., Billiau, A., DeSomer, P. (1978). Human Interferon: Large Scale Production in Embryo Fibroblast Cultures. In: Stinebring, W.R., Chapple, P.J. (eds) Human Interferon. Advances in Experimental Medicine and Biology, vol 110. Springer, New York, NY. https://doi.org/10.1007/978-1-4615-9080-4_5
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9080-4_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4615-9082-8
Online ISBN: 978-1-4615-9080-4
eBook Packages: Springer Book Archive